Medical Marijuana 411 values providing our readers with information about the latest cannabis related topics for educational purposes and not for the intention of advocacy. This is not an advocacy-based organization. For ailment specific questions, please consult your primary care physician.
16 Oct

The British Government Is Backing CBD

UK Medicines and Healthcare Products Regulatory Agency Approves CBD The British government on Tuesday announced it is backing products containing a specific cannabinoid (a component of marijuana). Government health authorities have  given private companies 28 days to get licenses to sell their products. The UK Medicines and Healthcare Products Regulatory Agency will approve products with the

Continue Reading

29 Jun

GW Announces UK Launch of World’s First Prescription Cannabis Medicine

Sativex®, available as a prescription only medicine, was developed by GW in specific response to calls from people with MS for a prescription cannabis-based medicine. Today’s launch means that MS patients suffering the spasms and cramping associated with spasticity have access to a new treatment option which has been shown to improve their symptoms where current treatments have failed.

Sativex® is manufactured by GW under Home Office licence at an undisclosed location in the UK. The medicine is being marketed in the UK by GW’s UK licensee, Bayer Schering Pharma.

Continue Reading